Prudential plc · PUK · FY2023 Q1 · Calendar Q1 2024
Prudential outlines health, China mix and ASEAN growth priorities
The current analysis supports a constructive operating thesis: strong 2023 growth, health expansion, China product-mix improvement and ASEAN distribution could support continued growth. The thesis remains dependent on execution, sustainable bank-assurance margins and effective deployment of planned investment.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about PUK FY2023 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management highlighted a stronger health-growth agenda, a China product-mix shift away from the 3.5% guaranteed product, broader ASEAN bank partnerships and continued investment in distribution, customer experience and claims technology.
Guidance delta
Maintained: management reiterated a 15–20% new-business-profit growth target through 2027.
Key takeaways
- 2023 sales reached $5.9bn, up 37%, while new-business profit reached $3.1bn, up 45%.
- Hong Kong gained share in domestic and Mainland Chinese visitor segments.
- China is shifting toward a more balanced product mix, with health and protection identified as growth areas.
- Management plans more than $1bn of capability investment in distribution, customer experience and claims technology.
Management priorities
- Expand bank-distribution partnerships across ASEAN.
- Double the health business by 2027 through standalone products and claims-cost efficiencies.
- Deploy the remaining $900m investment across distribution platforms, customer-experience tools and health AI.
Follow PUK with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Goldman Sachs | Buy | Buy | Maintain | Feb 14, 2022 |
| HSBC | Buy | Hold | Upgrade | Mar 23, 2021 |
| Macquarie | Outperform | Outperform | Maintain | Oct 3, 2019 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 10, 2018 |
| JP Morgan | Neutral | Underweight | Upgrade | Mar 17, 2017 |
| Societe Generale | Sell | Hold | Downgrade | Oct 13, 2016 |
| Jefferies | Hold | Buy | Downgrade | Jul 20, 2015 |
| Charles Stanley | Buy | Accumulate | Maintain | Jun 10, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $23.92. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Berenberg Bank | Michael Huttner | $39.3 | $27.29 | +64.3% | Sep 3, 2026 |
Track every rating change on PUK the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPrudential plc, operating through its various subsidiaries, delivers a diverse array of financial solutions to individuals across Asia and Africa, encompassing life and health coverage, retirement planning, and comprehensive asset management services. Its product portfolio includes extensive health and protection plans, along with various savings instruments such as participating, unit-linked, and conventional policies.…
Historical context
All PUK earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FDS FactSet Research Systems Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.9% | +3.8% | FactSet reports record FY26 results as AI and MCP adoption accelerate |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
Latest beats and misses
Who reports nextBeat on EPS
Get the PUK recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-11T06:39:45.180704+00:00
- Polygon adjusted daily market bars · 2026-10-11T06:20:43.720272+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-11T06:20:43.717342+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-11. For educational purposes only; not investment advice.